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Abstract
Mutations in the CLN6 gene cause a variant late infantile form of neuronal ceroid lipofuscinosis (NCL; Batten disease). CLN6
loss leads to disease clinically characterized by vision impairment, motor and cognitive dysfunction, and seizures.
Accumulating evidence suggests that alterations in metal homeostasis and cellular signaling pathways are implicated in
several neurodegenerative and developmental disorders, yet little is known about their role in the NCLs. To explore the
disease mechanisms of CLN6 NCL, metal concentrations and expression of proteins implicated in cellular signaling pathways
were assessed in brain tissue from South Hampshire and Merino CLN6 sheep. Analyses revealed increased zinc and
manganese concentrations in affected sheep brain in those regions where neuroinflammation and neurodegeneration first
occur. Synaptic proteins, the metal-binding protein metallothionein, and the Akt/GSK3 and ERK/MAPK cellular signaling
pathways were also altered. These results demonstrate that altered metal concentrations, synaptic protein changes, and
aberrant modulation of cellular signaling pathways are characteristic features in the CLN6 ovine form of NCL.
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Introduction
Neuronal ceroid lipofuscinoses (NCLs; Batten disease) are a
group of inherited, progressive neurodegenerative diseases of
childhood (recently reviewed in [1]. They represent the most
common neurodegenerative disorder of children with an incidence
of up to 1:12500 [2]. The estimates of incidence are rapidly
increasing with better diagnosis. There are at least eight different
childhood forms of NCL, distinguished by the age of onset and the
genetic defect, and three adult forms of the disease [3–5].
Although traditionally described by the ages of onset, all NCL
forms share similar clinical and pathological features. Clinical
symptoms include vision impairment, motor dysfunction, cognitive
dysfunction and seizures, and ultimately lead to premature death.
Pathological features of the disease include neuronal degeneration
and glial activation. Fluorescent lysosome-derived storage bodies
accumulate in most tissues. These contain protein, specifically
subunit c of mitochondrial ATP synthase in CLN2, CLN3, CLN5,
CLN6, CLN7 and CLN8, and SAPs A and D in the CLN1 and
CLN10 forms [6–8]. Four of the causative NCL genes, CLN1,
CLN2, CLN5 and CLN10, code for soluble lysosomal proteins
and the rest are membrane bound, associated with the
endosomal/lysosomal organelles, endoplasmic reticulum (ER),
and synaptic vesicles [9]. The physiological functions of all the
NCL proteins and the pathophysiological mechanisms underlying
the NCLs remain unclear.
The CLN6 protein is a highly conserved transmembrane
protein of unknown function that has been localized to the ER
[10,11]. As studies in human NCLs are restricted, naturally
occurring animal models of the disease are an important resource
for deciphering the disease mechanisms. Sheep are a well-
characterized, naturally occurring animal model for CLN6 disease
in which the phenotype resembles the human disease [12–14].
They have a complex central nervous system (CNS) and a
prolonged disease progression similar to human CLN6 disease,
easily observable at the age of 10–14 months, increasing blindness
being the leading clinical sign. Neuropathology is characterized by
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cortical neurodegeneration, which begins in the visual, parietal
and occipital cortex at four months of age, then spreads to other
regions [15]. This is preceded by activation of astrocytes and
microglia, which begins perinatally in the same regions before
spreading [16]. The balance of interneuron populations changes
[17] while some regions of the brain remain unaffected [18]. On
the other hand, storage body accumulation occurs similarly across
all brain regions, and is notable in cells not subject to
neurodegeneration, indicating that it does not play a central role
in the pathogenic cascade [15].
Accumulating evidence suggests that altered metal homeostasis
is a common pathological feature of several neurodegenerative
diseases, including Alzheimer’s disease, Parkinson’s disease, and
motor neuron disease (reviewed in [19,20] but also of develop-
mental disorders such as autistic spectrum disorder [21] and
neurodegeneration with brain iron accumulation [22]. Zinc, in
particular, is an important transition metal linked with physiology
and pathology in the CNS (reviewed in [23]). Zinc functions as an
essential component of many proteins and acts as a signaling
messenger at synapses. It has an important role in intracellular
signaling pathways that regulate both cell survival and death. Cells
are vulnerable to changes in zinc concentration, which are
regulated by transporter proteins [23] and by metal-binding
proteins such as metallothionein (MT) [24].
It is increasingly evident that metals play a complex role in
neurodegenerative disease, yet there is little knowledge of the role
of metals in NCL affected brains. Changes in some metal
concentrations, including iron and zinc in blood cells from
patients with NCL were reported [25]. In a larger study of NCL
patients, no association between ‘loosely bound’ iron or copper
levels in cerebrospinal fluid could be found [26]. Early studies on
the metal contents of storage material from CLN6 sheep revealed
no obvious association between metal contents and disease
progress [27]. They varied between storage material from different
tissues in line with the normal role of lysosomes as storage depots
for metals, indicating the lysosomal origin of the storage material.
Changes in the metal contents of retina and retinal pigment
epithelial cells of CLN6 sheep have been reported, and an
association with storage material accumulation and altered
manganese concentrations with increasing photoreceptor cell loss
suggested [28]. General brain metal contents in CLN6 and
unaffected animals or human NCL patients have not been
compared.
In the present study, we have begun to investigate the role of
biometals in the South Hampshire and Merino ovine models of
CLN6 disease. The most striking finding was a substantial zinc,
and to a lesser extent manganese, accumulation in specific regions
of the affected brain. This accumulation was evident at 12–14
months of age as were aberrant activation of cellular signaling
cascades and changes to synaptic proteins. These data suggest that
altered brain metal concentrations and disturbances of cellular
signaling pathways are a feature of ovine CLN6 disease.
Materials and Methods
Animals and materials
Sheep were maintained under standard New Zealand or
Australian pasture conditions on a University research farm. All
animal procedures were carried out according to NIH guidelines
and the New Zealand Animal Welfare Act (1999) or the New
South Wales Animal Research Act (1985) [13]. All animal work
was performed using standard operating procedures and this study
was approved by the Lincoln University Animal Ethics Commit-
tee. CLN6 affected Merino sheep have a c184C.T mutation and
the South Hampshire sheep display reduced CLN6 mRNA.
Unaffected South Hampshire and Merino sheep, and CLN5
(Borderdale) heterozygous (CLN5+/2, unaffected) animals [29]
were used as controls. Brain samples were collected from five 12–
14 month-old control and seven CLN6 affected sheep. At post
mortem, each brain was dissected into the occipital lobe, parietal
lobe, frontal lobe, thalamus, cerebellum and brain stem, and
immediately frozen. All reagents used were analytical grade.
Metal analyses
The metal content in six regions of the sheep brain was
measured using inductively coupled plasma mass-spectrometry
(ICP-MS) as previously described [30]. Weighed tissue pieces were
lyophilized, digested in 150–400 ml of 65% nitric acid (Merck,
Kilsyth, Victoria, Australia) overnight, and heated for a further 20
min at 90uC. Then 400 ml of BDH prolabo 30% hydrogen
peroxide (VWR, Murrarie, QLD, Australia) was added to each
sample and incubated at room temperature for 30 min, then for a
further 15 min at 70uC. All samples were diluted 1:20 with 1%
nitric acid before being measured in an Agilent 7700 series ICP-
MS instrument (Agilent Technologies, Santa Clara, CA, USA)
using a helium reaction gas cell. The instrument was calibrated
using 0, 5, 10, 50, and 100 ppb of certified multi-element ICP-MS
standard calibration solutions (Accustandard, New Haven, CT,
USA) for a range of elements. 200 ppb of yttrium (Y89) was used
as an internal control. Samples were analyzed in triplicate and
median values were used for analyses. The results are expressed as
micrograms of metal per gram of wet weight (mg/g).
Western blots
Brain tissues were homogenized with a Dounce tissue grinder in
5 volumes of Novagen Phosphosafe extraction reagent (Merck)
containing protease inhibitor cocktail (Roche). The protein
concentrations of supernatants after centrifugation (12,000 g,
5 min, 4uC) were measured with a Pierce BCA assay kit (Thermo
Scientific, Scoresby, Victoria, Australia) according to manufactur-
er’s instructions. Cortical neurons were harvested into Phospho-
safe extraction reagent containing protease inhibitor cocktail as
above. Proteins were separated on 12% SDS-PAGE tris-glycine
gels, electrophoretically transferred to PVDF membranes for
immunoblotting, and blocked with 4% skim milk in phosphate
buffered saline pH 7.4 (PBS)-0.05% Tween. Membranes were
probed with polyclonal antisera, all from Cell Signaling Technol-
ogy (Danvers, MA, USA), for total- or phospho- ERK1/2, Akt,
GSK3, p38, MAPK, syntaxin-6, GAPDH, ß-tubulin and ß-actin.
The synaptophysin antiserum was purchased from Millipore
(Billerica, MA, USA) and the metallothionein antibody was from
Abcam (Cambridge, MA, USA). The horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antiserum (Cell
Signaling Technology) was used at 1:5,000 dilution. Membranes
were developed by chemiluminescence using an Amersham ECL
Advance Western blotting detection kit, (GE Healthcare, Rydal-
mere, NSW, Australia) and imaged on a Fujifilm LAS3000 Imager
(Berthold, Bundoora, Australia). Western blots were subjected to
densitometry analysis using ImageJ software. Target band intensity
was compared to the intensity of control bands. Densitometric
quantification of phosphorylated Akt and phosphorylated GSK3ß
were performed as follows: both the phosphorylated form and total
form were first normalized to the loading control, GAPDH. The
ratio of normalized phospho-protein to total protein was then
shown in the figures. Data are shown as means 6 S.D.
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Statistical analyses
The co-relations of genotypes and brain regions to changes in
metal concentrations were examined using 2-way ANOVA in
SPSS 18.0 software (Softonic, Barcelona, Spain). If either
statistically significant main effects or interactions of brain region
and genotype were detected, simple main effects tests were
performed to determine those brain regions in which the
genotypes had different metal concentrations. Student’s t-test in
GraphPad Prism 5d (GraphPad Software, La Jolla, CA, USA) was
used for densitometry of Western blots. Data are shown as means
6 S.D.
Results
Elevated zinc and manganese in CLN6 ovine brain
The metal concentrations in the occipital lobe, parietal lobe,
frontal lobe, thalamus, cerebellum, and brainstem of 12–14 month
old CLN6 affected (Merino and South Hampshire background),
control (Merino and South Hampshire background), and hetero-
Figure 1. Altered metal concentrations in CLN6 disease affected brain. Metal concentrations in the occipital lobe, parietal lobe, frontal lobe,
thalamus, cerebellum, and brainstem of 12–14 month old Merino and South Hampshire (SH) CLN6 and Merino and South Hampshire control sheep
were measured using ICP-MS. The metal concentrations in each brain region are expressed relative to control metal concentrations. Error bars
represent S.D. values. ***p,0.001, **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0058644.g001
Figure 2. Reduction of metallothionein and synaptic proteins in CLN6 affected brain. (A) Occipital lobe homogenate from control and
CLN6 affected sheep was immunoblotted with an antibody for metallothionein I/II and b–tubulin as loading control. (B) Five micrograms of
homogenate from occipital and parietal lobe from 12–14 month old control (CTRL1), CLN5 heterozygote (CTRL2) and CLN6 homozygote sheep were
immunoblotted with an antibody for synaptophysin and GAPDH as loading control. (C) Twenty micrograms of homogenate from occipital and
parietal lobe were immunoblotted with an antibody for syntaxin-6 and b-tubulin as loading control.
doi:10.1371/journal.pone.0058644.g002
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zygous CLN5 (Borderdale background) sheep were measured
using ICP-MS. This is the age of onset for readily detectable
symptomatic changes in the affected animals. Eight metal
concentrations were significantly different in the CLN6 affected
ovine brain samples when compared to controls (Fig. 1). Others
were similar for controls and CLN6 sheep (Fig. S1) and the
concentrations of a further 11 metals (B, Ni, Ge, Se Ga, Ge, Mo,
Cd, Ba, W and Pb) were at or below the limit of detection.
Zinc concentrations were significantly higher in the CLN6
affected sheep when compared to controls in all brain regions
analyzed except cerebellum (Fig. 1A). Accumulation was most
pronounced in the occipital and parietal lobes of affected animals.
Interestingly, the metal differences between brain regions within
both control and affected animals were also significant (p,0.001).
The amount of manganese was also increased in the occipital,
parietal, and frontal lobes, and thalamus and brainstem of the 12–
14 month old affected compared to control sheep (Fig. 1B). Cobalt
concentrations changed with both mutations (p,0.001) and brain
region (p,0.001) (Fig. 1C). Sodium and potassium concentrations,
two ions essential for maintenance of the membrane potential, also
changed in the CLN6 sheep brain (Fig. 1D and E). Out of the 30
metals analyzed potassium (Fig. 1E) and magnesium (Fig. 1G)
were the sole elements in which a reduction was observed in the
brains of CLN6 affected sheep. Copper concentrations were
increased in the parietal lobe of affected animals (Fig. 1F) and iron
was increased in the frontal lobe and brain stem of CLN6 sheep
(Fig. 1H). Magnesium concentrations were altered in all brain
regions of CLN6 animals (Fig. 1G).
As a further control, metal concentrations were also measured
in CLN5+/2 brains (on a Borderdale background). CLN5 +/2
sheep do not become disease-affected. The metal concentrations in
CLN5 heterozygotes were not significantly different when
compared to control South Hampshire or Merino brains (data
not shown) providing further evidence that breed alone does not
significantly affect brain metal concentrations at this age.
Elevated metallothionein in CLN6 ovine brain
The expression of metallothionein, a metal-sequestering protein,
was increased in the occipital lobe of CLN6 affected sheep
(Fig. 2A). The expression of both the 7 kDa form (calculated
molecular weight form) and polymerized high molecular forms
migrating at approximately 23 kDa and 50 kDa were increased in
the affected brain. These higher molecular weight forms have been
consistently reported in diverse tissues and animals [31–33].
Synaptic protein changes in CLN6 affected brain
As it is known that synaptic pathology occurs in mice modeling
CLN6 disease [34], we hypothesized that synaptic alterations
would also be evident in the sheep model of disease. The
expression of two important markers of synaptic integrity,
synaptophysin and syntaxin-6, were measured. Both were reduced
in the occipital lobes of the affected sheep brain when compared to
either normal or CLN5 heterozygous controls (Fig. 2B, 2C).
Moreover, synaptophysin was also reduced in the parietal lobes of
affected animals (Fig 2B). No consistent changes in expression
were found in the other brain regions.
Figure 3. Expression of protein kinase Akt in disease-affected
regions of CLN6 sheep brain. (A) Thirty micrograms of homogenate
from occipital lobe, parietal lobe and frontal lobe from 12–14 month old
control (CTRL1), CLN5 heterozygote (CTRL2) and CLN6 homozygote
sheep were immunoblotted with an antibody against phosphorylated
Akt and GAPDH as loading control. Fifteen micrograms of homogenate
were immunoblotted with an antibody for total Akt and GAPDH as
loading control. Densitometric quantification of phosphorylated Akt
levels to total Akt was performed as outlined in Materials and Methods.
(B) Homogenate from thalamus, cerebellum, and brainstem were
immunoblotted with an antibody for phosphorylated Akt, total Akt and
GAPDH as loading control as in Figure 3A.
doi:10.1371/journal.pone.0058644.g003
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Altered phosphorylation of cellular signaling proteins in
the CLN6 affected brain
The Akt/GSK3 signaling cascade and the MAPK/ERK
pathway can be activated by small increases in cytosolic zinc
[35,36]. These pathways were examined by Western blotting to
determine any possible relationship to changed zinc concentra-
tions. In particular the activation status of Akt, a protein kinase
activated by PI3K that subsequently phosphorylates and inacti-
vates GSK3, was assessed to determine if the Akt/GSK3 signaling
pathway was affected by loss of CLN6. An increase in Akt
phosphorylation (Ser473) was evident in the occipital and parietal
lobes of CLN6 affected sheep (Fig. 3A), but not in the other brain
regions (Fig. 3B). To determine if activation of one of the main
downstream targets of Akt, GSK3, was also altered in the affected
brain samples, total GSK3 and GSK3 phosphorylated at Ser21/
Ser9 were assessed. Phosphorylated GSK3ß was reduced in the
occipital lobe of CLN6 affected sheep (Fig 4A). Changes were not
observed in the other brain regions (Fig.4A, 4B). Taken together,
these data suggest that the activation of the Akt/GSK3 signaling
pathway is altered in CLN6 affected brains in a region-specific
manner.
Phosphorylation to activate ERK1/2 (phosphorylated at
Thr202/Tyr204) increased in the occipital lobes of the affected
sheep (Fig. 5A). Total ERK1/2 was unchanged in all of the
samples (Fig. 5B) and there was no change to the expression of
other members of the MAPK/ERK pathway, such as p38 MAPK
or CREB (Fig. S2). In addition, there was no change to oxidative
stress related proteins such as heme oxygenase -1 and nuclear
factor erythroid 2 related factor-2, or to c-Jun N-terminal kinase,
in the CLN6 affected brain (data not shown).
Discussion
Metal analysis in the ovine CLN6 model of NCL revealed
changes to specific metal concentrations in the affected brain.
Accumulation of zinc and manganese was evident in those brain
regions known to undergo early neurodegeneration [15]. The
current study also demonstrated aberrant modulation of cellular
signaling pathways, the metal sequestering protein MT, and
alterations to synaptic proteins.
The CLN6 affected sheep appear to be normal for the first few
months of life until the most notable disease symptom, blindness,
becomes obvious at the age of 10–14 months [12,37]. The
mammalian occipital lobe receives and interprets visual sensory
messages and contains the primary visual cortex and the parietal
lobe is also involved with visuo-spatial processing. These were the
two regions that are affected early in ovine CLN6 disease and
showed the greatest degree of change in metal concentrations in
this study.
While zinc concentrations are not elevated in the cerebrospinal
fluid of CLN6 affected sheep (Palmer DN, unpublished data),
further studies are required to assess if metal concentrations in the
blood of CLN6 affected sheep correlate with those found in the
brain. It would also be interesting to determine if brain metal
concentrations are elevated at earlier ages. While the data
presented here show a significant increase in localized metal
Figure 4. Altered activation of GSK3 in disease-affected brain
regions of CLN6 affected sheep. (A) Thirty micrograms of
homogenate from occipital lobe, parietal lobe and frontal lobe from
12–14 month old control (CTRL1), CLN5 heterozygote (CTRL2) and CLN6
homozygote sheep were immunoblotted with an antibody against
phosphorylated GSK3, and GAPDH as loading control. Twenty
micrograms of homogenate were immunoblotted with an antibody
for total Akt and GAPDH as loading control. Densitometric quantifica-
tion of phosphorylated GSK3ß levels to total GSK3ß was performed as
outlined in Materials and Methods. Only the phospho-GSKß band was
quantified. (B) Homogenate from thalamus, cerebellum, and brainstem
were immunoblotted with an antibody for phosphorylated GSK, total
GSK3ß, and GAPDH as loading control as in Figure 4A.
doi:10.1371/journal.pone.0058644.g004
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concentrations in CLN6 ovine brain, it is not known if this is a
driving factor in disease pathogenesis or a consequence of
neuropathological changes.
Previous reports suggest concentrations of zinc in the sheep
brain to be approximately in the range of 4–10 mg/g, depending
on the region studied, and the manganese concentrations in the
range of 0.3–0.6 mg/g [38,39] consistent with the control data
here. While there is little knowledge of metal amounts in the brains
of sheep affected by disease, it has been shown that zinc and
manganese concentrations are elevated by approximately 22% in
scrapie-infected sheep [38]. In sheep infected with parasitic
psoroptic mange the brain concentration of zinc is reduced by
39% [40]. In the current study, the zinc and manganese
concentrations in the occipital lobe of CLN6 affected sheep were
increased. Whether these increases are sufficient or prolonged
enough to have a subsequent detrimental effect on brain function
or are reflective of changes in signaling activity is yet to be
established. It is also yet unclear whether the observed changes
directly cause neuroinflammation and cell death or whether they
occur as a result of these changes.
It should be noted that sub-cellular or localized metal
concentrations also vary substantially. Synaptic zinc concentra-
tions are reported to reach 300 mM [41] while major intracellular
storage sites for zinc, such as lysosomes may contain zinc at
concentrations of ,300 mg/g tissue or higher [42,43]. The
increases in metal concentrations reported here could reflect
substantially larger changes within localized regions or subcellular
organelles in the brain. A previous report described the presence of
metals including zinc, manganese, copper and iron in lysosome-
derived storage bodies isolated from several different ovine CLN6
tissues including the brain [27]. However, the broad range of
metal concentrations between tissues did not support a contrib-
utory role in storage body formation. Therefore, the sub-cellular
localization of increased metal concentrations determined in the
present study is unlikely to be associated with storage bodies but
may reflect higher concentrations in active subcellular compart-
ments.
Zinc is involved in a variety of neuronal functions, has an
important role in synaptic transmission (reviewed in [44]) and
serves as a structural component of approximately 10% of cellular
proteins [45]. The physiological functions of zinc in the CNS
depend on a balance between intra- and extra-cellular zinc
concentrations. Because zinc can become toxic at unregulated
concentrations these are tightly controlled by a variety of zinc-
regulating systems, in which zinc transporters and zinc-sequester-
ing proteins play an important role. Both zinc and manganese
share some similar cellular transport systems, including the
divalent metal transporter 1 and some of the ZIP transporter
proteins [46–49]. ATP13A2 is a predicted transmembrane
cationic metal transporter, which normally localizes to the
lysosome and endosome [50]. When mutated, ATP13A2 mis-
localizes to the endoplasmic reticulum [51,52] where the
transmembrane CLN6 protein is also located. Mutations in
ATP13A2 have been identified in a familiar form of Parkinson’s
disease [53] and more recently in NCLs [49,54,55] suggesting that
Figure 5. Activation of ERK in disease-affected regions of CLN6
sheep brain. (A) Thirty micrograms of homogenate from occipital
lobe, parietal lobe, frontal lobe, thalamus, cerebellum, and brainstem
from 12–14 month old control (CTRL1), CLN5 heterozygote (CTRL2) and
CLN6 homozygote (CLN6) sheep were immunoblotted with an antibody
against phosphorylated ERK1/2 and GAPDH as loading control. (B)
Twenty micrograms of homogenates from occipital lobe, parietal lobe,
frontal lobe, thalamus, cerebellum, and brainstem were immunoblotted
with an antibody for total ERK1/2, and GAPDH as loading control.
doi:10.1371/journal.pone.0058644.g005
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metal transporters are important, yet relatively little explored in
these diseases.
Metals are sequestered by proteins such as the metallothioneins
which regulate intracellular free metal concentrations. The
substantial increase in metallothionein in the affected sheep brain
coincides with increased metal concentrations in this study.
Because zinc-mediated up-regulation of metallothioneins [56] is
suggested to be a protective measure against cellular damage it is
possible that the increase in metal concentration and metallothio-
nein are linked and serve as an attempt at cellular repair in the
affected sheep brain. The fact that the levels of ceruloplasmin,
another metal carrier protein implicated in iron homeostasis,
correlate with neurological dysfunction in patients with CLN3
disease [57] suggests that metal-binding proteins may play an
important role in NCLs.
Metals can activate several cellular signaling pathways. The
ERK1/2 and Akt-GSK3ß pathways are important signaling
cascades that regulate cell proliferation, migration and survival.
Both are also implicated in neuronal death associated with
disorders of the CNS [58]. In this study, we have demonstrated
that the ERK1/2 and Akt-GSK3ß signaling pathways are altered
in the brains of CLN6 affected sheep at the time of observable
blindness. These results are consistent with previous observations
that alterations to GSK3 activation are a common, important
feature of several neurodegenerative diseases [59]. At this point it
is not clear whether the observed changes are the cause or
consequence of the disease process. While it is interesting to
speculate that the local increases in zinc levels in the CLN6
affected sheep may be responsible for the activation of the kinase
pathways, further temporal studies are warranted to assess if metal
accumulation leads to alterations of cellular phosphatases and
sustained ERK1/2 activation in the CLN6 affected brain. Further
studies are also required to tease out the precise role of these
kinases in the disease process.
Manganese is an essential element that is required for
maintaining proper cellular function, yet chronic overexposure
of humans to manganese causes manganism, a neurological
disease resembling Parkinson’s disease [60]. Interestingly, man-
ganism and CLN6 disease share some common pathological
characteristics such as cognitive impairment, motor dysfunction
and visual impairment [48]. While further studies are clearly
required to delineate the consequences of manganese accumula-
tion, it is tempting to speculate that the increase in manganese in
the brains of CLN6 affected sheep may be linked to some clinical
features of the disease. As manganese accumulation is known to be
neurotoxic, it is possible that the increase in manganese
concentration in the CLN6 affected brains could be detrimental
to the normal function of neurons. Previously it has been reported
that levels of manganese superoxide dismutase (MnSOD) are
increased in the CLN6 cortex [61]. It remains to be determined if
there is an association between the changes in manganese levels in
affected brain regions and MnSOD expression or activity.
In addition to zinc and manganese, the concentrations of cobalt,
sodium, magnesium and potassium differed in the CLN6 affected
brains when compared to controls. Sodium and potassium ions are
important for maintaining the neuronal resting and action
potentials, and the sodium-potassium pump is the major pump
for the exchange of these ions in neurons. The increase in sodium
and concomitant reduction in potassium in the CLN6 affected
sheep suggests an imbalance in the concentrations of these two
metals in the affected brain. It has been reported that the CLN3
protein, associated with a juvenile form of NCL, may interact with
the sodium potassium pump on the plasma membrane [62]. The
significance of this is unknown but could have implications for
control of ion movement in NCLs.
Further to our investigation of metal concentrations, we assessed
the expression of synaptic proteins in the CLN6 affected brains, as
synaptic loss is a characteristic feature of several neurodegener-
ative diseases. Synaptic proteins are reduced in the CLN6 form of
NCL in those brain regions affected by the pathology. These
synaptic changes are likely to reflect the underlying neuronal
deterioration associated with neurodegeneration. However, there
may be a more direct association between metal alterations and
synaptic changes. Our previous studies revealed that altered metal
concentrations in the brain are associated with changes to synaptic
function and protein expression [63]. Alterations in synaptic
proteins also occur early in the pathogenesis of the mouse model of
CLN6 disease, the Cln6nclf mice [34]. SNAP25 and synaptophysin
immunoreactivity are reduced in the thalamus of the Cln6nclf mice
at an early symptomatic age and continue to decrease as the
disease progresses. Moreover, it has been shown that altered
neurite maturation resulting from the loss of CLN6 interaction
with collapsing response mediator protein -2 could result in the
inability of CLN6 deficient neurons to form new synapses [64].
Our findings of reduced synaptic proteins in the ovine CLN6
model provide further evidence for synaptic vulnerability in NCLs.
Our results provide the first evidence that metal concentrations
and the metal-binding protein MT are altered in specific brain
regions of CLN6 affected animals and warrant investigation of
metal homeostasis in other forms of NCLs. In addition, synaptic
changes and activation of cellular signaling pathways were
identified in the same brain regions as altered metal concentra-
tions. Ultimately, therapeutic approaches targeted at metals and
inhibition of kinases may be feasible for the NCLs.
Supporting Information
Figure S1 Metal concentrations in the occipital lobe,
parietal lobe, frontal lobe, thalamus, cerebellum, and
brainstem of 12–14 month old CLN6 and control sheep
were measured using ICP-MS. The metal concentrations in
each brain region are expressed relative to control metal
concentrations. Error bars represent S.D.
(EPS)
Figure S2 Occipital lobe homogenates from 12–14
month old control (CTRL1), CLN5 heterozygote (CTRL2)
and CLN6 homozygote (CLN6) sheep were immuno-
blotted with an antibody for phosphorylated CREB and
phosphorylated p38 MAPK. b-tubulin antibody was used as a
loading control.
(TIF)
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